BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8637250)

  • 1. RT-PCR in acute promyelocytic leukemia: second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994.
    Leukemia; 1996 Feb; 10(2):368-71. PubMed ID: 8637250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of minimal residual disease in a patient with acute promyelocytic leukemia by RT-PCR: necessity of chemotherapy following ATRA therapy.
    Sun T; Takatsuki H; Yamashita S; Yufu Y; Umemura T; Nishimura J; Nawata H
    Fukuoka Igaku Zasshi; 1994 Feb; 85(2):52-6. PubMed ID: 8144129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA; Marenco P; Bianchi C; Cairoli R; Urbano M; Nosari AM; Muti G; Morra E; Del Monte U
    Leukemia; 1996 Feb; 10(2):207-12. PubMed ID: 8637228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
    Fukutani H; Naoe T; Ohno R; Yoshida H; Kiyoi H; Miyawaki S; Morishita H; Sano F; Kamibayashi H; Matsue K
    Leukemia; 1995 Apr; 9(4):588-93. PubMed ID: 7723389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR.
    Caprodossi S; Pedinotti M; Amantini C; Santoni G; Minucci S; Pelicci PG; Fanelli M
    Mol Biotechnol; 2005 Jul; 30(3):231-8. PubMed ID: 15988048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of PML/RARalpha impairs myelopoiesis.
    Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid.
    Levine K; DeBlasio A; Miller WH
    Leukemia; 1994 Apr; 8 Suppl 1():S116-20. PubMed ID: 8152276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial insertion of RARĪ± gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17).
    Goldschmidt N; Yehuda-Gafni O; Abeliovich D; Slyusarevsky E; Rund D
    Hematology; 2010 Oct; 15(5):332-7. PubMed ID: 20863428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia.
    Koller E; Karlic H; Krieger O; Mistrik M; Michlmayr G; Gadner H; Lutz D; Heinz R; Pittermann E
    Ann Hematol; 1995 Feb; 70(2):75-8. PubMed ID: 7880927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
    Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
    Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
    Kohli V; Koller CA
    Blood; 1995 Feb; 85(3):854-5. PubMed ID: 7833490
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
    Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
    Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
    Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
    Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
    Miller WH
    Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.